You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Modeling and Optimizing Turbines for Unsteady Flow

    SBC: ILLINOISROCSTAR LLC            Topic: ST13A005

    We propose a combined modeling and experimental program to analyze and optimize a turbine behind a pulse detonation combustor/engine (PDC/PDE). In Phase I, a discontinuous-Galerkin, harmonic balance code from the University of Cincinnati (UC) will be impl

    STTR Phase I 2013 Department of DefenseDefense Advanced Research Projects Agency
  2. Automatic Detection and Patching of Vulnerabilities in Embedded Systems

    SBC: GRAMMATECH INC            Topic: SB131003

    Recent studies have shown that embedded systems are extremely vulnerable to security attacks. Some published exploits include remote hijacking of the electronic systems in a modern car and using IP phones and smart televisions to perform covert surveillance of their owners. In this project, we propose a protection system that automatically detects and removes vulnerabilities from embedded software ...

    SBIR Phase I 2013 Department of DefenseDefense Advanced Research Projects Agency
  3. Surface Enhanced Raman Scattering-Based Oxytocin Quantitation

    SBC: Ionica Sciences, Inc            Topic: SB132001

    The ability to readily and rapidly detect the concentration of the 9- and 12-amino acid oxytocin analogs will significantly enhance the efficacy of understanding the conditions under which oxytocin is employed by the body. Ionica Sciences will take advantage of recent miniaturization of highly sensitive instrumentation that allows field application of surface enhanced Raman scattering (SERS), a sp ...

    SBIR Phase I 2013 Department of DefenseDefense Advanced Research Projects Agency
  4. Online Graphic Novel/Sequential Art Authoring Tools for Therapeutic Storytelling

    SBC: E-Line Ventures, LLC            Topic: SB112003

    Addressing PTSD and related stress reactions by Service Members and Veterans is one of our country's most important public health challenges. Art therapy has been recognized as a powerful tool enabling"trauma survivors to symbolically express, process and contain feelings they find difficult or impossible to put in to words"(Buk, 2009). Enabling Service Members and Veterans to tell their st ...

    SBIR Phase II 2013 Department of DefenseDefense Advanced Research Projects Agency
  5. Genetically Programmable Spherical Nucleic Acids as Rapidly Adaptable Nanotherapeutics

    SBC: Exicure, Inc.            Topic: SB121003

    AuraSense Therapeutics is developing oligonucleotide-modified gold nanoparticles called Spherical Nucleic Acid (SNA) constructs, which are a powerful new way of regulating cellular gene expression. AuraSense Therapeutics will use SNAs as genetically programmable antimicrobial agents in a manner to provide a rapid and effective way to develop next-generation antibacterial agents. The outcome of thi ...

    SBIR Phase II 2013 Department of DefenseDefense Advanced Research Projects Agency
  6. PNA-Based Rapidly Adaptable Anti-Microbial Nanoparticles

    SBC: AGAVE BIOSYSTEMS INC.            Topic: SB121003

    Wound management becomes increasingly challenging due to bacterial infections, especially from epidemic drug-resistant strains. To address this problem, Agave BioSystems proposes to develop a RANT (Rapidly Adaptable Nanotherapeutics) breadboard system built upon the modules successfully established in Phase I of this work. The proposed breadboard system will use genomic sequencing data generated ...

    SBIR Phase II 2013 Department of DefenseDefense Advanced Research Projects Agency
  7. Tumor-toxic CD47 mAb therapy for leukemia: a proof of concept study

    SBC: VASCULOX, INC.            Topic: NCI

    DESCRIPTION (provided by applicant): CD47 has emerged as a novel therapeutic target in hematologic cancers. Leukemias expressing the highest levels of CD47 have the worst prognosis. Increased CD47 expression is thought to protect cancer cells from phagocytic clearance by sending a don't eat me signal to macrophages via SIRPa, an inhibitory receptor that prevents phagocytosis of CD47-bearing ...

    STTR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
  8. Clinical Translation of an Anti-Metastatic Antibody for Breast Cancer Therapy

    SBC: FOR-ROBIN, INC.            Topic: NCI

    DESCRIPTION (provided by applicant): This proposal aims to develop a novel, highly-specific targeted therapy for treatment of breast cancer. The long-term objective is to convert the proprietary intellectual property, the mouse monoclonal antibody (McAb)JAA-F11, which targets the pancarcinoma Thomsen-Friedenreich antigen (TF-Ag) to a humanized form for use as an adjunct with conventional therapy ...

    STTR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
  9. Screens for Novel Agonists/Antagonists of Endocrine Fibroblast Growth Factors

    SBC: AGAVE BIOSYSTEMS INC.            Topic: NIDDK

    DESCRIPTION (provided by applicant): Agave BioSystems and Professor Makoto Kuro-o at the University of Texas Southwestern Medical Center are proposing a collaborative effort to screen for novel small molecules acting as agonists or antagonists of the Klotho and Klotho- dependent endocrine Fibroblast Growth Factors. The expected outcome of this Phase I effort will be the validation of a high-throug ...

    STTR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
  10. New drug VS-110 for treating inflammatory bowel diseases

    SBC: Vidasym, Inc            Topic: NIDDK

    DESCRIPTION (provided by applicant): Inflammatory bowel diseases (IBD) involve chronic inflammation of all or part of the digestive tract. Symptoms may include abdominal pain, severe diarrhea and malnutrition. IBD primarily includes ulcerative colitis (UC)and Crohn's disease (CD). In the West, the prevalence has increased in the past 50 years to 120-200/100,000 persons for UC and 50-200/100,0 ...

    STTR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government